Humana (HUM) stock gained 5% on Wednesday. What’s behind the move: The health insurer reported a strong quarter while reaffirmed its adjusted full-year profit outlook, expecting at least $9 per share.

Humana (HUM) stock slides despite a Q1 beat as the company reaffirmed its 2026 EPS guidance due to Medicare Star Ratings cuts. Read more here.

Shares of UnitedHealth Group (NYSE:UNH | UNH Price Prediction) are up 4% at midday Tuesday, trading near $368, while Humana (NYSE:HUM) stock is also up 4% to $233. Both managed care names are extending one of the most aggressive sector rebounds of 2026.

Humana (HUM) stock fell more than 2% in premarket trading on Wednesday. What’s behind the move: The health insurer reported a strong quarter but reiterated its adjusted full-year profit outlook, expecting at least $9 per share.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

Humana (NYSE:HUM) has appointed Robert S. Field to its Board of Directors, expanding its governance bench with a healthcare investment specialist. Field brings experience across healthcare investments and legal and regulatory issues,

Humana Inc. HUM stock rose on Wednesday after the health insurer released its first-quarter earnings. Earnings Beat Expectations Despite Year-Over-Year Profit Decline The company reported first-quarter adjusted income of $10.

Humana ( (HUM)) has provided an announcement. At Humana Inc.’s regular annual meeting of stockholders held on April 16, 2026, shareholders elected all ten nominees to the board of directors, each to serve until the next annual meeting or until a successor is chosen.